“…Developmental biologists typically are well aware of the potential of their work to have some impact upon human health, and are able to describe it in that context. A summary of the clinical importance of congenital heart defects (CHD) is a common introduction in reports of various kinds of experiments that utilize animal models to study heart development (e.g., Conway et al, ; Kirby and Sahn, ; Linask and Huhta, ; Rosenquist et al, ) or human population‐based studies of congenital heart defects (e.g., Botto et al, ; Hoffman and Kaplan, ; Pierpont et al, ; Hobbs et al, ; van der Linde et al, ). These data provide an excellent rationale for either animal model or population‐based studies, and may be summarized briefly as follows: - CHD is the most common congenital defect worldwide, effecting 1–10% of live births (this variability results from different study populations, differing criteria for inclusion of different types of CHD in the data analysis, variations in the sensitivity of the tools used to detect CHD, and other factors).
- CHD is the most common cause of infant mortality in the United States and Europe.
- The cumulative cost of CHD in dollars or euros is in the hundreds of millions annually.
- It is assumed that a large proportion of stillbirths are the result of CHD, so the actual number of CHD would be much higher.
…”